An advisory panel for the U.S. Food and Drug Administration has recommended emergency use authorization, or EUA, for the two-dose Novavax COVID-19 vaccine for people 18 and over. But unlike other ...

Aug 5 (Reuters) - The United States has administered more than 7,300 doses of Novavax Inc's (NVAX.O), opens new tab COVID-19 shot, which health officials hope will convince more people to opt for ...

Novavax, sold under the brand name Nuvaxovid, is a protein-based COVID-19 vaccine — the same technology used to develop many other common vaccines, including those for influenza and shingles.

Novavax, Inc. (NASDAQ:NVAX) is back in the spotlight as its stock skyrockets following a wave of positive news about its COVID-19 vaccine. The FDA has notified Novavax that it completed the filing ...

Aug 8 (Reuters) - Novavax Inc on Monday halved its full-year revenue forecast as it does not expect further sales of its COVID-19 shot this year in the United States in the face of a global supply ...